Adjuvant chemotherapy
2 papers2 findings
- 1 lab in 1 country
- Funder: National Institutes of Health
- Human trial1
- Humans1
Associations
2GrimAge
upin humans1
1 study
GrimAge
upin humans1
Adjuvant chemotherapy is associated with GrimAge in humans (0.29 SD per 6 months (95% CI 0.13–0.46); approximately 1.2 years).
“followed by GrimAge acceleration (0.29 SD per 6 months, 95% CI: 0.13, 0.46; approximately 1.2 years).”
Human trialLongitudinal change during adjuvant chemotherapy for stage II-III colon cancerblood
Journal of the National Cancer Institute3 Aug 2026
DunedinPACE acceleration
upin humans1
1 study
DunedinPACE acceleration
upin humans1
Adjuvant chemotherapy is associated with DunedinPACE acceleration in humans (0.70 SD per 6 months (95% CI 0.41–0.98)).
“DunedinPACE acceleration showed the largest increase during treatment (0.70 SD per 6 months, 95% CI: 0.41, 0.98)”
Human trialLongitudinal change during adjuvant chemotherapy for stage II-III colon cancerblood
Journal of the National Cancer Institute3 Aug 2026
Latest
1 in 12 monthsJournal of the National Cancer Institute
Epigenetic aging during adjuvant chemotherapy for colon cancer and modification by a resistance training intervention
Randomised trial in peopleResistance training
Annals of Surgery
Grim Age, Grim Prognosis: Epigenetic Aging Predicts Pancreatic Surgery Risk
Cohort study of 332 peopleGrimAge